当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 现金流量表

天康生物

(002100)

  

流通市值:114.82亿  总市值:114.82亿
流通股本:13.65亿   总股本:13.65亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金12,534,991,914.768,142,789,800.334,151,172,156.117,779,967,165.9
  收到的税费返还---3,850,713.39
  收到其他与经营活动有关的现金150,122,205.0392,437,085.2925,731,811.79404,550,640.33
  经营活动现金流入小计12,685,114,119.798,235,226,885.624,176,903,967.8918,188,368,519.62
  购买商品、接受劳务支付的现金10,960,316,812.315,872,126,612.793,188,954,869.3216,422,448,004.42
  支付给职工以及为职工支付的现金598,847,958.12403,882,949.58163,202,298.77803,145,852.11
  支付的各项税费113,394,492.9689,307,127.341,682,811.42163,319,019.31
  支付其他与经营活动有关的现金610,887,997.05373,956,210.351,692,254.64418,593,903.85
  经营活动现金流出小计12,283,447,260.446,739,272,899.973,445,532,234.1517,807,506,779.69
  经营活动产生的现金流量净额401,666,859.351,495,953,985.65731,371,733.74380,861,739.93
二、投资活动产生的现金流量:
  收回投资收到的现金1,150,000,000255,000,000255,000,000366,399,874
  取得投资收益收到的现金18,656,811.649,656,811.649,656,811.64901,697.43
  处置固定资产、无形资产和其他长期资产收回的现金净额272,348.28272,348.28-4,152,333.55
  投资活动现金流入小计1,168,929,159.92264,929,159.92264,656,811.64371,453,904.98
  购建固定资产、无形资产和其他长期资产支付的现金283,524,862.57152,407,323.535,668,974.73378,950,382.13
  投资支付的现金1,177,000,000-145,000,0001,278,350,687.38
  取得子公司及其他营业单位支付的现金562,409,619.47562,409,619.47--
  支付其他与投资活动有关的现金3,228,771.653,228,771.65-1,600,000
  投资活动现金流出小计2,026,163,253.69718,045,714.62180,668,974.731,658,901,069.51
  投资活动产生的现金流量净额-857,234,093.77-453,116,554.783,987,836.91-1,287,447,164.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金---200,870
  其中:子公司吸收少数股东投资收到的现金---200,870
  取得借款收到的现金5,849,882,7002,698,915,8001,450,000,0005,363,797,240.22
  收到其他与筹资活动有关的现金---2,361,300
  筹资活动现金流入小计5,849,882,7002,698,915,8001,450,000,0005,366,359,410.22
  偿还债务支付的现金4,261,317,8002,840,260,0001,188,664,734.325,408,058,877.06
  分配股利、利润或偿付利息支付的现金208,903,728.5171,614,883.4135,202,406.67442,613,863.34
  支付其他与筹资活动有关的现金---151,787,775.63
  筹资活动现金流出小计4,470,221,528.53,011,874,883.411,223,867,140.996,002,460,516.03
  筹资活动产生的现金流量净额1,379,661,171.5-312,959,083.41226,132,859.01-636,101,105.81
四、汇率变动对现金及现金等价物的影响----47,027.52
五、现金及现金等价物净增加额924,093,937.08729,878,347.541,041,492,429.66-1,542,733,557.93
  加:期初现金及现金等价物余额1,410,828,991.971,410,828,991.971,410,828,991.972,953,562,549.9
  期末现金及现金等价物余额2,334,922,929.052,140,707,339.512,452,321,421.631,410,828,991.97
补充资料:
  净利润--494,200,330.27-300,308,190.47
  资产减值准备-44,043,667.65-46,098,106.21
  固定资产和投资性房地产折旧-964,040,805.91-632,842,447.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-964,040,805.91-632,842,447.33
  无形资产摊销-16,040,564.41-26,096,302.42
  长期待摊费用摊销-7,533,058.44-15,690,865.66
  处置固定资产、无形资产和其他长期资产的损失--299,952.37--587,072.68
  固定资产报废损失-14,207,329.49-1,219,644
  公允价值变动损失--1,712,743.67--807,450.93
  财务费用-64,255,731.16-159,995,645.74
  投资损失--3,244,415.45--33,827,765.77
  递延所得税--18,682,177.64--12,654,496.6
  其中:递延所得税资产减少--14,469,191.12--13,116,112.93
    递延所得税负债增加--4,212,986.52-461,616.33
  存货的减少-1,242,311,286.64--969,266,841.41
  经营性应收项目的减少--149,811,612.27-148,490,390.26
  经营性应付项目的增加--303,038,537.93--236,861,500.52
  其他---131,543,845.6
  现金的期末余额-2,140,707,339.51-1,410,828,991.97
  减:现金的期初余额-1,410,828,991.97-2,953,562,549.9
  现金及现金等价物的净增加额-729,878,347.54--1,542,733,557.93
公告日期2026-10-262026-08-272026-04-302026-04-29
审计意见(境内)标准无保留意见
TOP↑